S Andrea Wijtenburg1, Jamie Near2,3,4, Stephanie A Korenic1, Frank E Gaston1, Hongji Chen1, Mark Mikkelsen5,6, Shuo Chen1, Peter Kochunov1,7, L Elliot Hong1, Laura M Rowland1,5,8. 1. Neuroimaging Research Program, Maryland Psychiatric Research Center, Department of Psychiatry, University of Maryland School of Medicine, Baltimore, Maryland, USA. 2. Centre d'Imagerie Cérébrale, Douglas Mental Health Institute, Montreal, Canada. 3. Department of Biomedical Engineering, McGill University, Montreal, Canada. 4. Department of Psychiatry, McGill University, Montreal, Canada. 5. Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. 6. F.M. Kirby Research Center for Functional Brain Imaging, Kennedy Krieger Institute, Baltimore, Maryland, USA. 7. Department of Physics, University of Maryland Baltimore County, Baltimore, Maryland, USA. 8. Department of Psychology, University of Maryland Baltimore County, Baltimore, Maryland, USA.
Abstract
BACKGROUND: Cerebral glutathione (GSH), a marker of oxidative stress, has been quantified in neurodegenerative diseases and psychiatric disorders using proton magnetic resonance spectroscopy (MRS). Using a reproducible MRS technique is important, as it minimizes the impact of measurement technique variability on the study results and ensures that other studies can replicate the results. HYPOTHESIS: We hypothesized that very short echo time (TE) acquisitions would have comparable reproducibility to a long TE MEGA-PRESS acquisition, and that the short TE PRESS acquisition would have the poorest reproducibility. STUDY TYPE: Prospective. SUBJECTS/PHANTOMS: Ten healthy adults were scanned during two visits, and six metabolite phantoms containing varying concentrations of GSH and metabolites with resonances that overlap with GSH were scanned once. FIELD STRENGTH/SEQUENCE: At 3T we acquired MRS data using four different sequences: PRESS, SPECIAL, PR-STEAM, and MEGA-PRESS. ASSESSMENT: Reproducibility of each MRS sequence across two visits was assessed. STATISTICAL TESTS: Mean coefficients of variation (CV) and mean absolute difference (AD) were used to assess reproducibility. Linear regressions were performed on data collected from phantoms to examine the agreement between known and quantified levels of GSH. RESULTS: Of the four techniques, PR-STEAM had the lowest mean CV and AD (5.4% and 7.5%, respectively), implying excellent reproducibility, followed closely by PRESS (5.8% and 8.2%) and SPECIAL (8.0 and 10.1%), and finally by MEGA-PRESS (13.5% and 17.1%). Phantom data revealed excellent fits (R2 ≥ 0.98 or higher) using all methods. DATA CONCLUSION: Our data suggest that GSH can be quantified reproducibly without the use of spectral editing. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:176-183.
BACKGROUND: Cerebral glutathione (GSH), a marker of oxidative stress, has been quantified in neurodegenerative diseases and psychiatric disorders using proton magnetic resonance spectroscopy (MRS). Using a reproducible MRS technique is important, as it minimizes the impact of measurement technique variability on the study results and ensures that other studies can replicate the results. HYPOTHESIS: We hypothesized that very short echo time (TE) acquisitions would have comparable reproducibility to a long TE MEGA-PRESS acquisition, and that the short TE PRESS acquisition would have the poorest reproducibility. STUDY TYPE: Prospective. SUBJECTS/PHANTOMS: Ten healthy adults were scanned during two visits, and six metabolite phantoms containing varying concentrations of GSH and metabolites with resonances that overlap with GSH were scanned once. FIELD STRENGTH/SEQUENCE: At 3T we acquired MRS data using four different sequences: PRESS, SPECIAL, PR-STEAM, and MEGA-PRESS. ASSESSMENT: Reproducibility of each MRS sequence across two visits was assessed. STATISTICAL TESTS: Mean coefficients of variation (CV) and mean absolute difference (AD) were used to assess reproducibility. Linear regressions were performed on data collected from phantoms to examine the agreement between known and quantified levels of GSH. RESULTS: Of the four techniques, PR-STEAM had the lowest mean CV and AD (5.4% and 7.5%, respectively), implying excellent reproducibility, followed closely by PRESS (5.8% and 8.2%) and SPECIAL (8.0 and 10.1%), and finally by MEGA-PRESS (13.5% and 17.1%). Phantom data revealed excellent fits (R2 ≥ 0.98 or higher) using all methods. DATA CONCLUSION: Our data suggest that GSH can be quantified reproducibly without the use of spectral editing. LEVEL OF EVIDENCE: 2 Technical Efficacy: Stage 2 J. Magn. Reson. Imaging 2019;49:176-183.
Authors: Charles Gasparovic; Tao Song; Deidre Devier; H Jeremy Bockholt; Arvind Caprihan; Paul G Mullins; Stefan Posse; Rex E Jung; Leslie A Morrison Journal: Magn Reson Med Date: 2006-06 Impact factor: 4.668
Authors: S Andrea Wijtenburg; Frank E Gaston; Elena A Spieker; Stephanie A Korenic; Peter Kochunov; L Elliot Hong; Laura M Rowland Journal: Magn Reson Med Date: 2013-10-22 Impact factor: 4.668
Authors: Shantel L Duffy; Jim Lagopoulos; Nicole Cockayne; Daniel F Hermens; Ian B Hickie; Sharon L Naismith Journal: J Affect Disord Date: 2015-03-14 Impact factor: 4.839
Authors: Li An; Yan Zhang; David M Thomasson; Lawrence L Latour; Eva H Baker; Jun Shen; Steven Warach Journal: J Magn Reson Imaging Date: 2009-08 Impact factor: 4.813
Authors: J Lagopoulos; D F Hermens; J Tobias-Webb; S Duffy; S L Naismith; D White; E Scott; I B Hickie Journal: J Psychiatr Res Date: 2013-01-08 Impact factor: 4.791
Authors: Brian P Brennan; J Eric Jensen; Christine Perriello; Harrison G Pope; Michael A Jenike; James I Hudson; Scott L Rauch; Marc J Kaufman Journal: Biol Psychiatry Cogn Neurosci Neuroimaging Date: 2016-02-01
Authors: L M Rowland; B W Krause; S A Wijtenburg; R P McMahon; J Chiappelli; K L Nugent; S J Nisonger; S A Korenic; P Kochunov; L E Hong Journal: Mol Psychiatry Date: 2015-03-31 Impact factor: 15.992
Authors: Nuno M P de Matos; Lukas Meier; Michael Wyss; Dieter Meier; Andreas Gutzeit; Dominik A Ettlin; Mike Brügger Journal: Front Hum Neurosci Date: 2016-06-21 Impact factor: 3.169
Authors: S Andrea Wijtenburg; Dimitrios Kapogiannis; Stephanie A Korenic; Roger J Mullins; Joyce Tran; Frank E Gaston; Shuo Chen; Maja Mustapic; L Elliot Hong; Laura M Rowland Journal: Schizophr Res Date: 2019-02-11 Impact factor: 4.939
Authors: Mollie A Monnig; Adam J Woods; Edward Walsh; Christina M Martone; Jonah Blumenthal; Peter M Monti; Ronald A Cohen Journal: Alcohol Alcohol Date: 2019-01-09 Impact factor: 2.826
Authors: Ofer M Gonen; Bradford A Moffat; Patrick Kwan; Terence J O'Brien; Patricia M Desmond; Elaine Lui Journal: Front Neurosci Date: 2020-09-15 Impact factor: 4.677
Authors: Tomohisa Okada; Hideto Kuribayashi; Lana G Kaiser; Yuta Urushibata; Nouha Salibi; Ravi Teja Seethamraju; Sinyeob Ahn; Dinh Ha Duy Thuy; Koji Fujimoto; Tadashi Isa Journal: Quant Imaging Med Surg Date: 2021-01
Authors: S Andrea Wijtenburg; Jeffrey West; Stephanie A Korenic; Franchesca Kuhney; Frank E Gaston; Hongji Chen; Laura M Rowland Journal: Front Psychiatry Date: 2021-04-01 Impact factor: 4.157